ASTEX Trademark

Trademark Overview

On Tuesday, November 17, 2015, a trademark application was filed for ASTEX with the United States Patent and Trademark Office. The USPTO has given the ASTEX trademark a serial number of 86823327. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2019. This trademark is owned by Astex Pharmaceuticals, Inc.. The ASTEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, oncological and hematological disorders
astex

General Information

Serial Number86823327
Word MarkASTEX
Filing DateTuesday, November 17, 2015
Status700 - REGISTERED
Status DateTuesday, March 5, 2019
Registration Number5692048
Registration DateTuesday, March 5, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2016

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, oncological and hematological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 21, 2015
Primary Code005
First Use Anywhere DateSunday, September 30, 2018
First Use In Commerce DateSunday, September 30, 2018

Trademark Owner History

Party NameASTEX THERAPEUTICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressCAMBRIDGE CB40QA
GB
Party NameAstex Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588
Party NameAstex Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588
Party NameAstex Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2016PUBLISHED FOR OPPOSITION
Friday, November 20, 2015NEW APPLICATION ENTERED
Saturday, November 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2016ASSIGNED TO EXAMINER
Wednesday, March 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2016SOU EXTENSION 1 FILED
Tuesday, December 6, 2016SOU EXTENSION 1 GRANTED
Friday, December 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, June 21, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017SOU EXTENSION 2 FILED
Sunday, July 2, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 13, 2017SOU EXTENSION 2 GRANTED
Friday, July 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2017SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2017SOU EXTENSION 3 FILED
Tuesday, December 19, 2017SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 14, 2018SOU EXTENSION 4 GRANTED
Thursday, May 31, 2018SOU TEAS EXTENSION RECEIVED
Thursday, May 31, 2018SOU EXTENSION 4 FILED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 18, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, December 18, 2018USE AMENDMENT FILED
Monday, January 7, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 31, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 5, 2019REGISTERED-PRINCIPAL REGISTER
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 10, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

astex disorders namely oncological hematological diseases diagnosis pharmaceutical preparations pharmaceuticals treatment